Back to Search Start Over

A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease

Authors :
Roberto Dominici
Carlo Lovati
Giulia Malferrari
Dario Finazzi
Massimo Musicco
Monica Cattaneo
Ida Biunno
Luciano Milanesi
Andrea Caprera
Giuliana Saltini
Pierluigi Bertora
Elio Scarpini
Claudio Mariani
Stefania Michelini
Eliana Venturelli
Daniela Galimberti
Fulvio Adorni
Source :
Neuroscience letters, 398 (2006): 53–58. doi:10.1016/j.neulet.2005.12.038, info:cnr-pdr/source/autori:Saltini, G; Dominici, R; Lovati, C; Cattaneo, M; Michelini, S; Malferrari, G; Caprera, A; Milanesi, L; Finazzi, D; Bertora, P; Scarpini, E; Galimberti, D; Venturelli, E; Musicco, M; Adorni, F; Mariani, C; Biunno, I/titolo:A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease/doi:10.1016%2Fj.neulet.2005.12.038/rivista:Neuroscience letters (Print)/anno:2006/pagina_da:53/pagina_a:58/intervallo_pagine:53–58/volume:398
Publication Year :
2006
Publisher :
Elsevier BV, 2006.

Abstract

Alzheimer's disease (AD) is considered to be a conformational disease arising from the accumulation of misfolded and unfolded proteins in the endoplasmic reticulum (ER). SEL1L is a component of the ER stress degradation system, which serves to remove unfolded proteins by retrograde degradation using the ubiquitin-proteosome system. In order to identify genetic variations possibly involved in the disease, we analysed the entire SEL1L gene sequence in Italian sporadic AD patients. Here we report on the identification of a new polymorphism within the SEL1L intron 3 (IVS3-88 A>G), which contains potential binding sites for transcription factors involved in ER-induced stress. Our statistical analysis shows a possible role of the novel polymorphism as independent susceptibility factor of Alzheimer's dementia. (C) 2005 Published by Elsevier Ireland Ltd.

Details

ISSN :
03043940
Volume :
398
Database :
OpenAIRE
Journal :
Neuroscience Letters
Accession number :
edsair.doi.dedup.....e19c9d17ae09d89d2fb32de4e79022c9